---
title: "AIMEI HEALTH TECHNOLOGY CO LTD COM USD0.0001 (SUB/RIGHTS 17/11/2028) | 10-Q: FY2025 Q3 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/266434374.md"
datetime: "2025-11-18T21:09:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266434374.md)
  - [en](https://longbridge.com/en/news/266434374.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266434374.md)
generator: "portal-rs"
---

# AIMEI HEALTH TECHNOLOGY CO LTD COM USD0.0001 (SUB/RIGHTS 17/11/2028) | 10-Q: FY2025 Q3 Revenue: USD 0

Revenue: As of FY2025 Q3, the actual value is USD 0.

EPS: As of FY2025 Q3, the actual value is USD 0.06.

EBIT: As of FY2025 Q3, the actual value is USD -612.32 K.

### Segment Revenue

-   The company has not generated any operating revenue as of September 30, 2025, as it is a blank check company focused on identifying a target for a business combination.

### Operational Metrics

-   **Net Income**: For the nine months ended September 30, 2025, net income was $961,651, compared to $2,108,102 for the same period in 2024. For the three months ended September 30, 2025, net income was $352,019, compared to $743,510 for the same period in 2024.
-   **Formation and Operating Costs**: For the nine months ended September 30, 2025, formation and operating costs were $585,170, compared to $662,765 for the same period in 2024. For the three months ended September 30, 2025, these costs were $130,152, compared to $200,019 for the same period in 2024.

### Cash Flow

-   **Operating Cash Flow**: Net cash used in operating activities was - $521,868 for the nine months ended September 30, 2025, compared to - $477,158 for the same period in 2024.
-   **Investing Cash Flow**: Net cash provided by investing activities was $29,887,800 for the nine months ended September 30, 2025.
-   **Financing Cash Flow**: Net cash used in financing activities was - $29,391,161 for the nine months ended September 30, 2025.

### Unique Metrics

-   **Interest Income**: Interest income earned on cash held in the Trust Account was $1,546,821 for the nine months ended September 30, 2025, compared to $2,770,867 for the same period in 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The company is focused on completing a business combination with United Hydrogen Group Inc. The business combination is expected to close in early 2026, subject to shareholder approvals and regulatory clearances.
-   **Non-Core Business**: The company has extended the timeframe to complete a business combination multiple times, with the current deadline set for December 6, 2025.

### Priority

-   The company emphasizes the completion of the business combination with United Hydrogen as a priority, with structured plans to meet the deadline and regulatory requirements.

### Related Stocks

- [AFJKR.US](https://longbridge.com/en/quote/AFJKR.US.md)

## Related News & Research

- [BREAKINGVIEWS-SpaceX gives wireless industry rude wake-up call](https://longbridge.com/en/news/298997206.md)
- [Trump Is Still Very Much Operating Off ‘Concepts’ Of A Health Care Plan](https://longbridge.com/en/news/298872418.md)
- [‘Beware the Trap,’ Says Investor About Oracle Stock](https://longbridge.com/en/news/298937750.md)
- [Costco Stock (COST) in Focus as Company Limits Motor Oil Purchases](https://longbridge.com/en/news/298953540.md)
- [Tesla sets up Vietnam unit, registration filing shows](https://longbridge.com/en/news/298873087.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**